Vineti

📍 San Francisco, United States🗓 Founded 2016👥 41 employees💰 Last funded May 2020
The proven software platform for cell and gene therapy supply chain management. From the beginning, Vineti’s founders have understood the challenges that biotech and pharmaceutical innovators face in developing personalized therapies. Vineti’s Personalized Therapy Management (PTM®) platform is the essential enterprise software to drive and scale global personalized therapies, such as cell therapies, gene therapies, and cancer vaccines. PTM® connects the right patient to the right product, on time and on track.
7
Total investors
4
Early stage
3
Mid stage
0
Late stage
2016
Founded
Investor geography1 country
United States
7
Investor activity2016–2020 · investors recorded per year
20161201712018220203
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Vineti?
Vineti has 7 investors on record on gritt.io, including 4 early-stage backers, 3 mid-stage.
When did Vineti last raise funding?
The most recent investment in Vineti recorded on gritt.io was in May 2020.
When was Vineti founded?
Vineti was founded in 2016.
What industry is Vineti in?
Vineti operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Vineti based?
Vineti is headquartered in San Francisco, United States.